Abstract
The inv(16) is one of the most frequent chromosomal translocations associated with acute myeloid leukemia (AML) and creates a chimeric fusion protein consisting of most of the runt-related X1 co-factor, core binding factor β fused to the smooth muscle myosin heavy chain MYH11. Expression of the ARF tumor suppressor is regulated by runt-related X1, suggesting that the inv(16) fusion protein (IFP) may repress ARF expression. We established a murine bone marrow transplant model of the inv(16) in which wild type, Arf +/-, and Arf-/- bone marrow were engineered to express the IFP. IFP expression was sufficient to induce a myelomonocytic AML even when expressed in wild type bone marrow, yet removal of only a single allele of Arf greatly accelerated the disease, indicating that Arf is haploinsufficient for the induction of AML in the presence of the inv(16). © 2005 by The American Society for Biochemistry and Molecular Biology, Inc.
Cite
CITATION STYLE
Moreno-Miralles, I., Pan, L., Keates-Baleeiro, J., Durst-Goodwin, K., Yang, C., Kim, H. G., … Hiebert, S. W. (2005). The inv(16) cooperates with ARF haploinsufficiency to induce acute myeloid leukemia. Journal of Biological Chemistry, 280(48), 40097–40103. https://doi.org/10.1074/jbc.M506855200
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.